Artelo Biosciences
ARTL
ARTL
3 hedge funds and large institutions have $43K invested in Artelo Biosciences in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$34K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$8K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
| 1 |
CH
1
CVI Holdings
Wilmington,
Delaware
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $34K | 15,624 | +15,624 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $8K | 3,630 | +3,630 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | 253 | +216 | +584% |
|
|
CH
4
CVI Holdings
Wilmington,
Delaware
| – | – | -41,126 | Closed |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|